Search results for " safety" in Articles / App Notes
								 					Article
				
				Reviewing the Importance of Biosimilarity and Interchangeability
								Establishing biosimilar analytical studies
	There are several key criteria to consider when establishing analytical studies for a biosimilar drug candidate to ensure its safety, efficacy, and similar…								
								 					Article
				
				Eliminating Residual Impurities Starts with a Strategic Plan
								…reduce the amount of testing needed while still meeting regulatory requirements and ensuring patient safety. It does require, however, a thorough understanding of the process combined with appropriat…								
								 					Article
				
				Labeling of Biosimilars
								Instead, a biosimilar has to demonstrate similarity to the reference product in terms of quality characteristics, biological activity, safety, and efficacy based on a comprehensive comparability exerc…								
								 					Article
				
				Critical Quality Attributes Challenge Biologics Development
								While CQAs of small-molecule drugs can affect the purity, strength, drug release, and stability of a drug, the complex nature of biologics can create additional quality attributes that can affect the …								
								 					Article
				
				Genetic Vaccine Platforms Demonstrate Their Potential
								Alternatively, vaccines can be classified into live and non-live vaccines, which is important when considering safety profiles.  
	
	
		Traditional vaccines and viral subunit/proteins directly elicit …								
								 					Article
				
				Updating Viral Clearance for New Biologic Modalities
								… used to ensure virus removal are well established and their effectiveness has been confirmed by the safety record of the therapeutics they were used to manufacture, adds Darren Verlenden, head of Bi…								
								 					Article
				
				Defining Critical Quality Attributes for Monoclonal Antibody Therapeutic Products
								Biotech therapeutics, particularly complex products such as monoclonal antibodies (mAbs), can have numerous quality attributes that can potentially impact safety and/or efficacy of the product (2). Id…								
								 					Article
				
				Elucidating Biosimilars Characterization
								Thus, a classical randomized crossover design as used for small molecules is not appropriate on safety and logistics grounds. Such studies, therefore, are most likely to use a parallel-group design, i…								
								 					Article
				
				Regulatory Challenges in the QbD Paradigm
								The key steps for QbD implementation include: identification of the product attributes that are of significant importance to the product's safety or efficacy (i.e., target product profile and critical…								
								 					Article
				
				A Look Ahead at BioPharma Manufacturing and Regulation
								The most common definition of regulatory science is a discipline that creates new tools, standards, and approaches for use in assessing the safety, effectiveness, quality, and performance of products.…